Last €39.35 EUR
Change Today -1.37 / -3.37%
Volume 920.0
As of 11:39 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for teva pharmaceutical-sp adr (TEV)

Year over year, Teva Pharmaceutical Industries Limited has seen net income shrink from $2.0B USD to $1.3B USD despite relatively flat revenues. A key factor has been an increase in the percentage of sales devoted to SGA costs from 25.19% to 26.18%.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Reclassified
Dec 31
2012
Dec 31
2013
4 Year
Trend
Revenues16,121.018,312.020,317.020,314.0
TOTAL REVENUES16,121.018,312.020,317.020,314.0
Cost of Goods Sold6,949.08,445.09,602.09,598.0
GROSS PROFIT9,172.09,867.010,715.010,716.0
Selling General & Admin Expenses, Total3,833.04,410.05,117.05,319.0
R&D Expenses951.01,095.01,356.01,427.0
OTHER OPERATING EXPENSES, TOTAL4,784.05,505.06,473.06,746.0
OPERATING INCOME4,388.04,362.04,242.03,970.0
Interest Expense-202.0-234.0-355.0-314.0
Interest and Investment Income57.044.026.026.0
NET INTEREST EXPENSE-145.0-190.0-329.0-288.0
Income (Loss) on Equity Investments-24.0-61.0-46.0-40.0
Currency Exchange Gains (Loss)-80.0-16.0-25.0-8.0
EBT, EXCLUDING UNUSUAL ITEMS4,139.04,095.03,842.03,634.0
Merger & Restructuring Charges-391.0-581.0-291.0-228.0
Gain (Loss) on Sale of Investments-----23.0-64.0
Other Unusual Items, Total-126.0-619.0-1,755.0-2,132.0
Legal Settlements-2.0-471.0-715.0-1,524.0
Other Unusual Items--53.08.0-145.0
EBT, INCLUDING UNUSUAL ITEMS3,622.02,895.01,773.01,210.0
Income Tax Expense283.0127.0-137.0-43.0
Minority Interest in Earnings-8.0-9.053.016.0
Earnings from Continuing Operations3,339.02,768.01,910.01,253.0
NET INCOME3,331.02,759.01,963.01,269.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS3,331.02,759.01,963.01,269.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS3,331.02,759.01,963.01,269.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEV:GR €39.35 EUR -1.37

TEV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $43.01 USD +0.115
AbbVie Inc $53.49 USD -0.59
Baxter International Inc $76.51 USD -0.49
Bristol-Myers Squibb Co $49.14 USD -0.325
Eli Lilly & Co $63.87 USD -0.50
View Industry Companies
 

Industry Analysis

TEV

Industry Average

Valuation TEV Industry Range
Price/Earnings 33.7x
Price/Sales 2.3x
Price/Book 2.0x
Price/Cash Flow 37.8x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.